| Drug General Information |
| Drug ID |
D09IBZ
|
| Former ID |
DNC000202
|
| Drug Name |
Aminoglutethemide
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Formula |
C13H16N2O2
|
| CAS Number |
CAS 125-84-8
|
| Target and Pathway |
| Target(s) |
Cytochrome P450 19 |
Target Info |
Inhibitor |
[1]
|
|---|
|
BioCyc Pathway
|
Superpathway of steroid hormone biosynthesis
|
|
Estradiol biosynthesis II
|
|
Estradiol biosynthesis I
|
|
KEGG Pathway
|
Steroid hormone biosynthesis
|
|
Metabolic pathways
|
|
Ovarian steroidogenesis
|
|
NetPath Pathway
|
FSH Signaling Pathway
|
|
PANTHER Pathway
|
Androgen/estrogene/progesterone biosynthesis
|
|
PathWhiz Pathway
|
Androgen and Estrogen Metabolism
|
|
Reactome
|
Endogenous sterols
|
|
WikiPathways
|
Metapathway biotransformation
|
|
Tryptophan metabolism
|
|
Oxidation by Cytochrome P450
|
|
Ovarian Infertility Genes
|
|
Metabolism of steroid hormones and vitamin D
|
|
FSH signaling pathway
|
|
Integrated Breast Cancer Pathway
|
|
Phase 1 - Functionalization of compounds
|
| References |
| REF 1 | Aromatase inhibitors and their use in the adjuvant setting. Recent Results Cancer Res. 1998;152:277-84. |
|---|
